Category: News

Empowering investors with access to the best research, experts and opportunities.

News

North Stawell Gold IPO closing soon

North Stawell Minerals (ASX: NSM) Gold IPO is closing this week. Whilst the deal is over subscribed Reach Markets has a small allocation that we expect to close out very soon. Click here to request a Prospectus and for the opportunity to participate in this IPO. 

Read more

The accidental fund manager

In the next episode of our exciting ‘Meet the Funds Manager’ webcast series we will be joined by Ron Shamgar, the Head of Australian Equities at Tamim Asset Management. The Tamin All Cap Fund performed exceptionally strongly through 2019, returning 55.78% (net of fees). And, so far in FY20, is 8.64% (net of fees) up for the year, after a strong July returned 11.34%.

Read more

Elsight on track to become the leading drone connectivity platform

The disruption caused by everyday activities being forced online due to COVID-19 social distancing cannot be underestimated. Entire multi-billion dollar industry verticals such as education, healthcare and security are all scrambling for short-term stop-gaps, many not recognising the permanence of the change brought about by the pandemic, which continues to spread across the world. 

Read more

Prescient Therapeutics adds Peter Mac collaboration to CAR-T focus

Australian listed biotechnology company Prescient Therapeutics (ASX: PTX) today updated the market on progress on one of its personalised cancer therapy drugs, PTX-100. The results of the Phase 1b study means that PTX-100 can now move to the next level dose with two out of three patients from the first cohort showing stable or improved disease.

Read more

Could the market collapse again?

When the market collapsed in March, it fell faster than the GFC. Yet it’s since rallied 35% and the V-shaped recovery is moving towards new highs. Meanwhile, there’s a discrepancy between the market’s behaviour and that of the wider economy. This could indicate we’re heading for another collapse.

Read more

Weekly Trade – Neutral – SEK (Seek Limited) – Iron Condor

Our trade of the week is a neutral SEK Iron Condor Trade flagged on Thursday the 13th of August. We have chosen this trade as it meets our quant tested Iron Condor trade criteria scoring 70 points which currently makes it a ‘Bronze’ level trade. Traders use the Iron Condor strategy to generate income in sideways markets by selling the Implied Volatility that is priced into the options and allowing time decay to erode the value of the sold legs, making them cheaper to buy back later, or ideally, allowing them to expire worthless.

Read more

PTX in pole position as race to cure cancer heats up

Australian listed biotechnology company Prescient Therapeutics (ASX: PTX) today updated the market on progress on one of its personalised cancer therapy drugs, PTX-100. The results of the Phase 1b study means that PTX-100 can now move to the next level dose with two out of three patients from the first cohort showing stable or improved disease.

Read more

Titomic leverages Australia’s untapped green tech potential

Titomic (AX: TTT) is an additive manufacturing company that showcases Australia’s potential in advanced, green technology. Titomic specialises in 3D printing high-performance metals for the same cost of traditional manufacturing. As well as producing metals, Titomic conducts its own Research & Development.

Read more

Gold explorer North Stawell Minerals launches IPO

As gold runs at all time highs and Victoria ushers in a new gold rush, North Stawell Minerals (ASX: NSM) has launched its initial public offering. Talk about perfect timing!The IPO will raise AUD $20 million through 40 million shares at $0.50 a piece.

Read more

Optima Nutricosmetics set for Harrods debut months after launch

Optima Nutricosmetics is an Australian nutricosmetics company that offers daily collagen-based supplements that promote skin and gut health.

Read more

Aussie biotech aims high in race to cure cancer

Every year 45,000 of the most respected professionals in oncology gather at the American Society of Clinical Oncology (ASCO) annual meeting. This year the meeting was abuzz with clinical research news about CAR T-cell therapy, including Johnson and Johnson reporting a 100% recovery rate from its ongoing multiple myeloma (Blood Cancer) trial. The headline grabbing efficacy number is that there are now 25 complete responders in the 29-strong Cartitude-1 dataset. Earlier data cut had reported 22 complete remissions.

Read more

Solving ESG reporting problems for the mining sector

Ever wonder how gold companies like Anglo Gold Ashanti, Gold Fields, Newcrest, Newmont or Kinross report their mineral inventory to the stock market? Many household names in the resources sector use or are implementing K2Fly’s Software as a Service (SaaS).

Read more

We prioritise transparency in everything we do; our primary objectives are your satisfaction and success.

Receive the latest news and media directly to your inbox

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.